Advanced or Metastatic Solid Tumors

Also known as: Advanced or Metastatic Solid Tumor

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB16423	AK119	1	Recruiting	1
DB15568	Adagrasib	1	Recruiting	1
DB00062	Albumin human	1	Active Not Recruiting	1
DB06626	Axitinib	1	Active Not Recruiting	1
DB00188	Bortezomib	1	Completed	1
DB16741	Bortezomib D-mannitol	1	Completed	1
DB16680	Cadonilimab	1	Recruiting	1
DB01101	Capecitabine	1	Completed	1
DB00958	Carboplatin	1	Active Not Recruiting	1
DB00002	Cetuximab	1	Recruiting	1
DB00515	Cisplatin	1	Active Not Recruiting	1
DB12483	Copanlisib	1	Completed	1
DB15769	Envafolimab	1	Completed	1
DB06080	Linifanib	1	Terminated	1
DB09035	Nivolumab	1	Active Not Recruiting	1
DB09035	Nivolumab	1	Suspended	1
DB01229	Paclitaxel	1	Active Not Recruiting	1
DB09037	Pembrolizumab	1	Active Not Recruiting	2
DB09037	Pembrolizumab	1	Not Yet Recruiting	1
DB00642	Pemetrexed	1	Active Not Recruiting	1
DB15078	Rogaratinib	1	Completed	1
DB05210	SF1126	1	Completed	1
DB12893	Sacituzumab govitecan	1	Recruiting	1
DB15765	Sintilimab	1	Terminated	1
DB15106	Surufatinib	1	Terminated	1
DB08937	TAS-102	1	Completed	1
DB14876	TAS-116	1	Recruiting	1
DB09343	Tipiracil	1	Enrolling by Invitation	1
DB00432	Trifluridine	1	Enrolling by Invitation	1
DB03754	Tromethamine	1	Completed	1
DB12723	Varlitinib	1	Completed	1
DB00928	Azacitidine	1 / 2	Completed	1
DB01101	Capecitabine	1 / 2	Terminated	1
DB00958	Carboplatin	1 / 2	Withdrawn	1
DB14707	Cemiplimab	1 / 2	Terminated	1
DB00515	Cisplatin	1 / 2	Terminated	1
DB05239	Cobimetinib	1 / 2	Active Not Recruiting	1
DB01248	Docetaxel	1 / 2	Withdrawn	1
DB11977	Golvatinib	1 / 2	Terminated	1
DB06186	Ipilimumab	1 / 2	Active Not Recruiting	1
DB06132	Nivolumab	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Active Not Recruiting	1
DB01229	Paclitaxel	1 / 2	Completed	1
DB01229	Paclitaxel	1 / 2	Withdrawn	1
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB09037	Pembrolizumab	1 / 2	Terminated	1
DB00642	Pemetrexed	1 / 2	Withdrawn	1
DB16406	Subasumstat	1 / 2	Recruiting	1
DB15149	Futibatinib	2	Recruiting	1
DB15102	Pemigatinib	2	Terminated	1